A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in U.S. adults by 2030.
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...
Korea Joongang Daily on MSN15h
Weight-loss drug Wegovy to hit market on TuesdayWeight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback